Metabolic changes in cancer cells upon suppression of MYC

Metabolic changes in cancer cells upon suppression of MYC

Bibliographic Details
Main Authors:	Anso, Elena, Mullen, Andrew R, Felsher, Dean W, Matés, José M, DeBerardinis, Ralph J, Chandel, Navdeep S
Format:	Online
Language:	English
Published:	BioMed Central 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178210/

Similar Items

Fundamentals of cancer metabolism
by: DeBerardinis, Ralph J., et al.
Published: (2016)

Metabolic heterogeneity in cancer
by: DeBerardinis, Ralph J
Published: (2014)

Q&A: Targeting metabolism to diagnose and treat cancer
by: DeBerardinis, Ralph J
Published: (2014)

Metabolic vulnerabilities of MYC-induced cancer
by: Gouw, Arvin M., et al.
Published: (2016)

Targeting glucose metabolism for cancer therapy
by: Hamanaka, Robert B., et al.
Published: (2012)

Mitochondrial metabolism in TCA cycle mutant cancer cells
by: Sullivan, Lucas B, et al.
Published: (2014)

Pyruvate dehydrogenase activity is required for optimal growth under lipid deficient conditions
by: Rajagopalan, Kartik, et al.
Published: (2014)

Reductive carboxylation supports growth in tumor cells with defective mitochondria
by: Mullen, Andrew R., et al.
Published: (2011)

Mitochondria and cancer
by: Chandel, Navdeep S
Published: (2014)

From “N of 1” to N of more
by: DeBerardinis, Ralph J., et al.
Published: (2015)

Metformin, mitochondria and cancer
by: Chandel, Navdeep S
Published: (2014)

Mitochondrial metabolism as a regulator of keratinocyte differentiation
by: Hamanaka, Robert B, et al.
Published: (2013)

Four key questions about metformin and cancer
by: Chandel, Navdeep
Published: (2014)

Mitochondrial reactive oxygen species and cancer
by: Sullivan, Lucas B, et al.
Published: (2014)

Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis
by: Griss, Takla, et al.
Published: (2015)

Mitochondria as signaling organelles
by: Chandel, Navdeep S
Published: (2014)

The cancer cell ‘energy grid’: TGF-β1 signaling coordinates metabolism for migration
by: Jiang, Lei, et al.
Published: (2015)

“Picolog,” a Synthetically-Available Bryostatin Analog, Inhibits Growth of MYC-Induced Lymphoma In Vivo
by: DeChristopher, Brian A., et al.
Published: (2012)

Functional Interactions between Retinoblastoma and c-MYC in a Mouse Model of Hepatocellular Carcinoma
by: Saddic, Louis A., et al.
Published: (2011)

Correction: Combined Analysis of Murine and Human Microarrays and ChIP Analysis Reveals Genes Associated with the Ability of MYC To Maintain Tumorigenesis
by: Wu, Chi-Hwa, et al.
Published: (2013)

Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
by: Wheaton, William W, et al.
Published: (2014)

Identifying metabolomic features that predict metastasis of melanoma from a primary site
by: Shi, Xiaolei, et al.
Published: (2014)

Metabolic diversity in human non-small cell lung cancer
by: Chen, Pei-Hsuan, et al.
Published: (2014)

Meta‐analysis of clinical metabolic profiling studies in cancer: challenges and opportunities
by: Goveia, Jermaine, et al.
Published: (2016)

FoxO3 suppresses Myc-driven lymphomagenesis
by: Vandenberg, C J, et al.
Published: (2016)

The role of c-Myc-RBM38 loop in the growth suppression in breast cancer
by: Xiao-Xia Li, et al.
Published: (2017-04-01)

Systemic Suppression of the Shoot Metabolism upon Rice Root Nematode Infection
by: Kyndt, Tina, et al.
Published: (2014)

Developmental Context Determines Latency of MYC-Induced Tumorigenesis
by: Beer, Shelly, et al.
Published: (2004)

Glutamine metabolism and the unfolded protein response in MYC-driven breast cancer
by: Shajahan-Haq, Ayesha, et al.
Published: (2014)

Strategically targeting MYC in cancer
by: Posternak, Valeriya, et al.
Published: (2016)

Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachone
by: Chakrabarti, Gaurab, et al.
Published: (2015)

c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism
by: Gao, Ping, et al.
Published: (2009)

Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addiction
by: Cetinbas, Naniye, et al.
Published: (2014)

SIRT1 and c-Myc Promote Liver Tumor Cell Survival and Predict Poor Survival of Human Hepatocellular Carcinomas
by: Jang, Kyu Yun, et al.
Published: (2012)

ELL targets c-Myc for proteasomal degradation and suppresses tumour growth
by: Chen, Yu, et al.
Published: (2016)

Myc coordinates transcription and translation to enhance transformation and suppress invasiveness
by: Elkon, Ran, et al.
Published: (2015)

The Tumor-Suppressive MicroRNA-135b Targets c-Myc in Osteoscarcoma
by: Liu, Zheng, et al.
Published: (2014)

The PVT1-MYC duet in cancer
by: Tseng, Yuen-Yi, et al.
Published: (2015)

MYC and integrins interplay in colorectal cancer
by: Boudjadi, Salah, et al.
Published: (2016)

HIF-2α Suppresses p53 to Enhance the Stemness and Regenerative Potential of Human Embryonic Stem Cells
by: Das, Bikul, et al.
Published: (2012)